HER3 and its Ligand, Heregulin, as Targets for Cancer Therapy

E-ISSN： 2212-3970|11|3|267-274

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.11, Iss.3, 2016-08, pp. : 267-274

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hepatocyte Growth Factor and Its Receptor Signalling Complex as Targets in Cancer Therapy

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 10, Iss. 1, 2010-01 ,pp. : 2-6

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular targets in cancer therapy

By Kummar Shivaani Doroshow James H

Expert Review of Anticancer Therapy, Vol. 13, Iss. 3, 2013-03 ,pp. : 267-269

Informa Healthcare

Access to resources Recommend Favorite

Molecular Targets of Omega-3 Fatty Acids for Cancer Therapy

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 15, Iss. 7, 2015-01 ,pp. : 888-895

Bentham Science Publishers

Access to resources Recommend Favorite

Glutathione Transferases as Targets for Cancer Therapy

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 7, 2009-09 ,pp. : 763-777

Bentham Science Publishers

Access to resources Recommend Favorite

RUNX3 and Retinoic Acid Receptor &bgr; DNA Methylation as Novel Targets for Gastric Cancer Therapy

Current Cancer Therapy Reviews, Vol. 1, Iss. 2, 2005-06 ,pp. : 139-144

Bentham Science Publishers

Access to resources Recommend Favorite